ID   NBR1_RAT                Reviewed;         983 AA.
AC   Q501R9; Q9JHG4;
DT   11-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   07-JUN-2005, sequence version 1.
DT   02-OCT-2024, entry version 109.
DE   RecName: Full=Next to BRCA1 gene 1 protein;
DE   AltName: Full=Neighbor of BRCA1 gene 1 protein;
GN   Name=Nbr1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-43.
RC   STRAIN=SHR; TISSUE=Testis;
RX   PubMed=11179671; DOI=10.1016/s0378-1119(00)00549-7;
RA   Dimitrov S., Brennerova M., Forejt J.;
RT   "Expression profiles and intergenic structure of head-to-head oriented
RT   Brca1 and Nbr1 genes.";
RL   Gene 262:89-98(2001).
RN   [3]
RP   INTERACTION WITH SQSTM1; TTN AND TRIM55, AND SUBCELLULAR LOCATION.
RX   PubMed=15802564; DOI=10.1126/science.1110463;
RA   Lange S., Xiang F., Yakovenko A., Vihola A., Hackman P., Rostkova E.,
RA   Kristensen J., Brandmeier B., Franzen G., Hedberg B., Gunnarsson L.G.,
RA   Hughes S.M., Marchand S., Sejersen T., Richard I., Edstroem L., Ehler E.,
RA   Udd B., Gautel M.;
RT   "The kinase domain of titin controls muscle gene expression and protein
RT   turnover.";
RL   Science 308:1599-1603(2005).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-592; SER-598 AND SER-855, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Ubiquitin-binding autophagy adapter that participates in
CC       different processes including host defense or intracellular
CC       homeostasis. Possesses a double function during the selective autophagy
CC       by acting as a shuttle bringing ubiquitinated proteins to
CC       autophagosomes and also by participating in the formation of protein
CC       aggregates. Plays a role in the regulation of the innate immune
CC       response by modulating type I interferon production and targeting
CC       ubiquitinated IRF3 for autophagic degradation (By similarity). In
CC       response to oxidative stress, promotes an increase in SQSTM1 levels,
CC       phosphorylation, and body formation by preventing its autophagic
CC       degradation (By similarity). In turn, activates the KEAP1-NRF2/NFE2L2
CC       antioxidant pathway (By similarity). Plays also non-autophagy role by
CC       mediating the shuttle of IL-12 to late endosome for subsequent
CC       secretion (By similarity). {ECO:0000250|UniProtKB:P97432,
CC       ECO:0000250|UniProtKB:Q14596}.
CC   -!- SUBUNIT: Homooligomer and heterooligomer (By similarity). Interacts
CC       with TRIM55 (PubMed:15802564). Interacts with titin/TTN
CC       (PubMed:15802564). Interacts with RNF29, USP8, MAP1LC3A, MAP1LC3B,
CC       MAP1LC3C, GABARAP, GABARAPL1 and GABARAPL2 (By similarity). Binds to
CC       ubiquitin and ubiquitinated proteins (By similarity). Interacts with
CC       SQSTM1 (PubMed:15802564). Interacts with TAX1BP1 (By similarity).
CC       Interacts with IRF3; this interaction mediates autophagic degradation
CC       of IRF3 (By similarity). Interacts with IL12A and IL12B (By
CC       similarity). {ECO:0000250|UniProtKB:P97432,
CC       ECO:0000250|UniProtKB:Q14596, ECO:0000269|PubMed:15802564}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q14596}.
CC       Cytoplasmic vesicle, autophagosome {ECO:0000250|UniProtKB:Q14596}.
CC       Lysosome {ECO:0000250|UniProtKB:Q14596}. Cytoplasm, myofibril,
CC       sarcomere, M line {ECO:0000269|PubMed:15802564}. Note=In cardiac
CC       muscles localizes to the sarcomeric M line (PubMed:15802564). Is
CC       targeted to lysosomes for degradation (By similarity).
CC       {ECO:0000250|UniProtKB:Q14596, ECO:0000269|PubMed:15802564}.
CC   -!- DOMAIN: The PB1 domain mediates interaction with SQSTM1. {ECO:0000250}.
CC   -!- PTM: Phosphorylated by GSK3A; this phosphorylation inhibits NBR1
CC       involvement in the formation of ubiquitinated protein aggregates.
CC       {ECO:0000250|UniProtKB:Q14596}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC095903; AAH95903.1; -; mRNA.
DR   EMBL; AF227190; AAF74120.1; -; mRNA.
DR   EMBL; AF227191; AAF74121.1; -; mRNA.
DR   RefSeq; NP_001019936.1; NM_001024765.1.
DR   AlphaFoldDB; Q501R9; -.
DR   SMR; Q501R9; -.
DR   BioGRID; 257580; 5.
DR   CORUM; Q501R9; -.
DR   STRING; 10116.ENSRNOP00000028149; -.
DR   CarbonylDB; Q501R9; -.
DR   iPTMnet; Q501R9; -.
DR   PhosphoSitePlus; Q501R9; -.
DR   PaxDb; 10116-ENSRNOP00000028149; -.
DR   GeneID; 303554; -.
DR   KEGG; rno:303554; -.
DR   UCSC; RGD:69195; rat.
DR   AGR; RGD:69195; -.
DR   CTD; 4077; -.
DR   RGD; 69195; Nbr1.
DR   eggNOG; KOG4351; Eukaryota.
DR   eggNOG; KOG4582; Eukaryota.
DR   InParanoid; Q501R9; -.
DR   OrthoDB; 5399396at2759; -.
DR   PhylomeDB; Q501R9; -.
DR   Reactome; R-RNO-9664873; Pexophagy.
DR   PRO; PR:Q501R9; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005776; C:autophagosome; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0005770; C:late endosome; ISS:UniProtKB.
DR   GO; GO:0005764; C:lysosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0031430; C:M band; IEA:UniProtKB-SubCell.
DR   GO; GO:0005758; C:mitochondrial intermembrane space; ISO:RGD.
DR   GO; GO:0005739; C:mitochondrion; ISO:RGD.
DR   GO; GO:0000407; C:phagophore assembly site; ISO:RGD.
DR   GO; GO:0043235; C:receptor complex; ISS:UniProtKB.
DR   GO; GO:0051019; F:mitogen-activated protein kinase binding; ISO:RGD.
DR   GO; GO:0043130; F:ubiquitin binding; ISS:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0016236; P:macroautophagy; ISS:UniProtKB.
DR   GO; GO:0045668; P:negative regulation of osteoblast differentiation; ISO:RGD.
DR   GO; GO:0030500; P:regulation of bone mineralization; ISO:RGD.
DR   GO; GO:0032872; P:regulation of stress-activated MAPK cascade; ISO:RGD.
DR   CDD; cd14947; NBR1_like; 1.
DR   CDD; cd06396; PB1_NBR1; 1.
DR   CDD; cd14319; UBA_NBR1; 1.
DR   CDD; cd02340; ZZ_NBR1_like; 1.
DR   Gene3D; 3.30.60.90; -; 1.
DR   Gene3D; 1.10.8.10; DNA helicase RuvA subunit, C-terminal domain; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 1.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR032350; N_BRCA1_central.
DR   InterPro; IPR053793; PB1-like.
DR   InterPro; IPR000270; PB1_dom.
DR   InterPro; IPR034852; PB1_NBR1.
DR   InterPro; IPR015940; UBA.
DR   InterPro; IPR009060; UBA-like_sf.
DR   InterPro; IPR000433; Znf_ZZ.
DR   InterPro; IPR043145; Znf_ZZ_sf.
DR   PANTHER; PTHR20930:SF2; NEXT TO BRCA1 GENE 1 PROTEIN; 1.
DR   PANTHER; PTHR20930; OVARIAN CARCINOMA ANTIGEN CA125-RELATED; 1.
DR   Pfam; PF16158; N_BRCA1_IG; 1.
DR   Pfam; PF00564; PB1; 1.
DR   Pfam; PF00569; ZZ; 1.
DR   SMART; SM00666; PB1; 1.
DR   SMART; SM00291; ZnF_ZZ; 1.
DR   SUPFAM; SSF54277; CAD & PB1 domains; 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   SUPFAM; SSF46934; UBA-like; 1.
DR   PROSITE; PS51745; PB1; 1.
DR   PROSITE; PS50030; UBA; 1.
DR   PROSITE; PS01357; ZF_ZZ_1; 1.
DR   PROSITE; PS50135; ZF_ZZ_2; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Cytoplasmic vesicle; Lysosome; Metal-binding; Phosphoprotein;
KW   Reference proteome; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..983
FT                   /note="Next to BRCA1 gene 1 protein"
FT                   /id="PRO_0000096749"
FT   DOMAIN          4..86
FT                   /note="PB1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01081"
FT   DOMAIN          930..974
FT                   /note="UBA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00212"
FT   ZN_FING         214..266
FT                   /note="ZZ-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00228"
FT   REGION          126..149
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          544..638
FT                   /note="ATG8 family proteins-binding"
FT                   /evidence="ECO:0000250"
FT   REGION          611..645
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          745..756
FT                   /note="ATG8 family proteins-binding"
FT                   /evidence="ECO:0000250"
FT   REGION          768..813
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          867..895
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        792..810
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         219
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00228"
FT   BINDING         222
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00228"
FT   BINDING         233
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00228"
FT   BINDING         236
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00228"
FT   BINDING         242
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00228"
FT   BINDING         245
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00228"
FT   BINDING         252
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00228"
FT   BINDING         256
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00228"
FT   MOD_RES         117
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14596"
FT   MOD_RES         588
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14596"
FT   MOD_RES         592
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         598
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         855
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
SQ   SEQUENCE   983 AA;  109829 MW;  4A80880D9EDDE729 CRC64;
     MEPQVTLNVT FKNETQSFLV SDPENTTWAD VEAMVKVSFD LNTIQIKYLD EENEEISINS
     QGEYEEALKM ANIKQGNQLQ MQVHEGCHVV DEVLPQTVVE KQATARTGKK PLAHYSSLVR
     VLGSDMKTTE EPTAEARSPV PCDTDKPQDK PPDWFTSYLE MFREQVVKET VEKLEQRLQE
     KLVLQKPPFS SSPSEVSMPI SEEETLFLPE NQFSWHIACS HCQKRIVGVR YQCSLCPSYN
     ICEDCEAGPY SHDTNHILLK FRRPVVISSE PFFYSKYPTP RLPAALEQVR LQKQVDKNFV
     KAEKQRLRAE KKQRKAEVKE LKKQLKLHRK IHLWNSIHGL QSPKSPLGRP ESLLQSNTLM
     LPLQPCAPVM PTLSAAFVDE NLPDGTHLQP GTKFIKHWRM KNTGNVKWSA DTKLKFMWGN
     LTLASTEKKD VLVPCLKAGH IGVVSVEFIA PTLEGTYTLH WRLSHKGQQF GPRVWCSIIV
     DPFPSSESPV NLERDGISSS KADDFTCEQE EAFLLAEEEI PLGEVTKQTE GTGSSAPQKT
     QHAASERELY IPSVDLLTAQ DLLSFELLDI NIVQELERVP HNTPVDVTPR MSPLPHDSPL
     IEKPGLGRIQ EESEGAGLKA SPDSTVLTKR KAETPASVEE TEEDLSGTQF VCETVIRSLT
     LDAAPDHNPP CRQRSPQREL QLYSTEEQQP LMLPGFCRKD SSLKFALPEE GPHGDEREEI
     VHIAEEEAIE EEDVQDEEVQ SQSSASSEDY IIILPECFDT SRPLGDSMYS SALSQPGLER
     GAEGEPGIES GQEPAEARER LPERESQPKE QSISDILTTS QHLDTVPLVP EVAGLPAALS
     RSAPCGQYEA PRVDSPVTIQ EVLPVPDHVR GEPRGSTGLA NSRQKSCDHS RHHNGSSIAG
     GLVKGALSVA ASAYKALFSG PPVTAQPVIS EDQTAALMAH LFEMGFCDRQ LNLRLLRKHN
     HNILQVVTEL LQVNNNDWYS HRY
//
